Comparative Pharmacology
Head-to-head clinical analysis: PROBAMPACIN versus UNIPEN IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PROBAMPACIN versus UNIPEN IN PLASTIC CONTAINER.
PROBAMPACIN vs UNIPEN IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
PROBAMPACIN is a synthetic aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, causing misreading of mRNA and preventing translocation of peptidyl-tRNA from the A-site to the P-site.
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity and peptidoglycan cross-linking.
100 mg IV every 12 hours over 30 minutes.
250-500 mg intravenously or intramuscularly every 4-6 hours. Maximum dose 12 g per day.
None Documented
None Documented
4.5 hours (prolonged to 12-18 hours in severe renal impairment)
0.5-1 hour (normal renal function); prolonged to 2-5 hours in renal impairment
Renal: 70% unchanged; biliary/fecal: 20% as metabolites; 10% other
Renal: 60-90% unchanged via glomerular filtration and tubular secretion; biliary/fecal: minor, <10%
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic